Crossmark

Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports

Crossref DOI link: https://doi.org/10.1186/s12916-021-02062-w

Published Online: 2021-08-25

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hodkinson, Alexander https://orcid.org/0000-0003-2063-0977
Heneghan, Carl

Mahtani, Kamal R.

Kontopantelis, Evangelos

Panagioti, Maria
Funding

Funding for this research was provided by:

NIHR School for Primary Care Research (NA)
License Information

Text and Data Mining valid from 2021-08-25

Version of Record valid from 2021-08-25
More Information

Article History

Received: 16 April 2021

Accepted: 13 July 2021

First Online: 25 August 2021

Declarations

:

: No ethics approval was required.

: All authors have read and approved the final manuscript.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below